An Update on Botulinum Toxin Therapy
Includes a Live Web Event on 06/17/2026 at 6:00 PM (CDT)
-
You must log in to register
- Member - $125
- Resident Member - Free!
- Allied Staff Member - $125
- Professional Staff Nonmember - $200
- Other Nonmember - $200
- Practice Management CE Subscriber - $125
- CE Subscriber (Clinical & PM) - $125
An Update on Botulinum Toxin Therapy
Botulinum toxin therapy has evolved from a cosmetic adjunct to a practical esthetic tool within oral and maxillofacial surgery. This 60-minute live webinar provides a current update on the science, indications, technique refinements, complication management and regulatory considerations surrounding botulinum toxin use in OMS practice. The session will focus on evidence-based applications for facial esthetics, temporomandibular disorders, bruxism, masseter hypertrophy, facial pain syndromes and perioperative adjunctive uses. Participants will review anatomy-driven injection strategies, dosing best practices, emerging literature and risk mitigation principles to optimize outcomes while protecting patient safety and practice compliance.
Learning Objectives
At the conclusion of this program, participants should be able to:
- Review the pharmacology and mechanism of action of botulinum toxin relevant to esthetic tool within oral and maxillofacial surgery.
- Identify current evidence-based indications and dosing strategies for botulinum toxin in facial cosmetic surgery, TMD management, bruxism and masseter hypertrophy.
- Apply anatomy-driven injection techniques to enhance safety, precision and esthetic outcomes while minimizing complications.
- Recognize and manage complications and regulatory considerations, including off-label use, documentation standards and risk mitigation in OMS practice.
Cancellation Policy: Registrants will receive a full refund up until the day before the event. No refund will be given on the day of or after the event.
Faisal A. Quereshy, DDS, MD, FACS
Professor, Residency Program Director
Faisal A. Quereshy, DDS, MD, FACS, is Medical Director of the Visage Surgical Institute. In addition to being a board-certified OMS, Dr. Quereshy is a board-certified facial cosmetic surgeon by the American Board of Cosmetic Surgery (ABCS) and the American Board of Facial Cosmetic Surgery (ABFCS).
He has served as President of ABFCS and President of the American College of Oral and Maxillofacial Surgeons (ACOMS). Dr. Quereshy is the Chair of the AAOMS Committee on Facial Cosmetic Surgery, liaison to the Committee on Continuing Education and Professional Development, and Chair of the Clinical Interest Group on Cosmetic Maxillofacial Surgery.
Disclosure(s): No financial relationships to disclose
Continuing Education Provider Approval
The American Association of Oral and Maxillofacial Surgeons is an ADA CERP Recognized Provider.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education.
ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.
The American Association of Oral and Maxillofacial Surgeons designates this activity for 1.0 continuing education credit(s).
AGD - Accepted Program Provider
FAGD/MAGD Credit
11/1/22-12/31/26
Provider ID# 214680
The American Association of Oral and Maxillofacial Surgeons (AAOMS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Association of Oral and Maxillofacial Surgeons designates this internet-based live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Key:
Complete
Next
Failed
Available
Locked